Enrichment analysis of genes dysregulated following Cytarabine treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013694
TitleEnrichment analysis of genes dysregulated following Cytarabine treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Cytarabine treated cells and untreated control cells in the diffuse large B cell lymphoma SKI-DLCL cells cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3088887
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatornbongio
CREEDS IDdrug:2599
Cell Typediffuse large B cell lymphoma SKI-DLCL cells
Drug NameCytarabine
DrugBank IDDB00987
Organismhuman
PubChem CID6253
SMILES IDC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O
Characteristic Direction parameters
Control SamplesGSM132917, GSM132918, GSM132920
Perturbed SamplesGSM132949, GSM132950, GSM132953
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE5681
Gene Expression Omnibus
Aplidin and cytarabine effect on diffuse large B cell lymphoma cell line
14
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.